Furthermore, this lncRNA can induce the expression of CCL2 in bladder cancer cells, upregulate CCL2 to stimulate TAMs to secrete VEGF-C, participate in lymphogenesis, promote lymphatic metastasis and lymphangiogenesis, and accelerate the invasiveness of bladder cancer cells. The gene discussed is CCL2; the disease is urinary bladder cancer.